) will begin trading ex-dividend on May 06, 2013. A cash dividend
payment of $1.8624 per share Shareholders who purchased SNY stock
prior to the ex-dividend date are eligible for the cash dividend
payment. This represents an 6.04% increase over the prior year.
The previous trading day's last sale of SNY was $55,
representing a 0% decrease from the 52 week high of $55 and a
66.52% increase over the 52 week low of $33.03.
SNY is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). SNY's current earnings per share, an indicator of a company's
profitability, is $2.02. Zacks Investment Research reports SNY's
forecasted earnings growth in 2013 as -7.06%, compared to an
industry average of -3.2%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to SNY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have SNY as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- BLDRS Europe 100 ADR Index Fund (
The top-performing ETF of this group is ADRU with an increase of
12.41% over the last 100 days. PPH has the highest percent
weighting of SNY at 6.15%.